PATHOPHYSIOLOGICAL BASIS OF MICROCIRCULATORY DISORDERS IN DIABETES MELLITUS
Keywords:
diabetes mellitus, microcirculation, endothelial dysfunction, oxidative stress, AGEs, microangiopathy.Abstract
This article analyzes the pathophysiological mechanisms of microcirculatory disorders in diabetes mellitus. The roles of chronic hyperglycemia, endothelial dysfunction, oxidative stress, and advanced glycation end products (AGEs) in the development of diabetic microangiopathy are discussed. Structural and functional alterations in capillary blood flow, basement membrane thickening, and pericyte loss are emphasized as key mechanisms leading to diabetic retinopathy, nephropathy, and neuropathy. Modern diagnostic approaches, including HbA1c, microalbuminuria, Doppler ultrasound, OCT, and biomarkers, are also reviewed.
References
1.American Diabetes Association. Standards of Care in Diabetes. 2024.
2.Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001.
3.Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiological Reviews, 2013.
4.Barrett E.J. et al. The vascular complications of diabetes. Circulation Research, 2017.
5.World Health Organization. Diabetes report. 2023.
6.Ceriello A. Hyperglycemia and oxidative stress. Diabetes Care, 2005.
7.DCCT Research Group. The effect of intensive diabetes therapy. NEJM, 1993.
8.Antonetti D.A. Diabetic retinopathy pathophysiology. Diabetes, 2012.
9.Forbes J.M. Oxidative stress in diabetic complications. Free Radical Biology, 2008.
10.Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circulation Research, 2010.
11.International Diabetes Federation (IDF). IDF Diabetes Atlas. 10th ed. Brussels, 2021.
12.Cooper M.E., El-Osta A. Epigenetics and diabetic complications. Diabetes, 2010.
13.Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation, 2006.
14.Stitt A.W., Curtis T.M. Advanced glycation and diabetic vascular disease. Current Pharmaceutical Design, 2010.
15.Vinik A.I., Nevoret M.L., Casellini C., Parson H. Diabetic neuropathy and microvascular dysfunction. Diabetes Care, 2013.
16.Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiological Reviews, 2013.
17.American Heart Association (AHA). Microvascular complications in diabetes mellitus. Circulation, 2019.
18.Eberhardt N.L., Creager M.A. Endothelial dysfunction in diabetes mellitus. Journal of Cardiovascular Pharmacology, 2007.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal